This study improves the characterization of the 10% of Portuguese CLL patients with major BcR stereotypes, offering healthcare providers better predictive power for disease progression and potentially impacting clinical decision making. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.